Activating point mutations in the Ras oncogene occur in a large number of human tumors, especially of epithelial origin. In thyroid follicular cells, ectopic expression of oncogenic H-Ras results in growth factor-independent proliferation, loss of dierentiation and tumor formation in nude mice. In ®broblasts concomitant activation of the MAP kinase cascade and the small GTPase Rac-1 leads to full malignant transformation. We have tested the eects of these key downstream mediators of Ras in thyroid epithelial cells, by stably expressing either a constitutively active form of MEK-1 (MEK DN3/S218E/S222D ), a constitutively active form of Rac-1 (Val12-Rac), or both. While the activation of one molecule or the other results in a weak phenotype, concomitant activation of both MEK-1 and Rac-1 in thyroid cells leads to growth factor-independent proliferation, morphological transformation and anchorage-independent growth. However, in contrast to Ras-transformed thyroid cells, the ones expressing the constitutively active forms of MEK-1 and Rac-1 maintain their dierentiate phenotype and fail to form tumors when injected into nude mice. Thus, in thyroid epithelial cells, concomitant activation of MEK-1 and Rac-1 can reproduce only a subset of the Rasinduced eects and is not sucient to cause full malignant transformation. Signi®cantly, Ras-mediated increased proliferation and loss of dierentiation can be dissociated in these cells.
Introduction
The Ras proteins H-, K-and N-Ras are central regulators in the transduction of extracellular signals, controlling cell growth and dierentiation (Barbacid, 1987; Khosravi-Far and Der, 1994) . They are membrane-bound guanine nucleotide-binding proteins, that become active in the GTP-bound state in response to ligand-stimulated receptors (Bourne et al., 1991) . Activating mutations of Ras have an impaired intrinsic GTPase activity and are insensitive to GTPaseactivating proteins (GAPs), resulting in constitutive signaling to downstream targets. Genetic and biochemical studies have revealed that Ras, in its active GTPbound form, can interact with multiple distinct eectors, inducing at least two distinct pathways that are necessary for its transformation ability, and act synergistically to induce malignant transformation (Joneson and Bar-Sagi, 1997; Joneson et al., 1996; Khosravi-Far et al., 1996; Marshall, 1996) .
Raf is a serine/threonine kinase, whose activation occurs through direct Ras-Raf interaction (Aelst et al., 1993; Vojtek et al., 1993; Warne et al., 1993; Zhang et al., 1993) and leads to activation of a kinase cascade consisting of mitogen-activated protein kinase (MAPK) kinases (MEK-1 and MEK-2), which in turn activate p42 and p44 MAPK/extracellular signalregulated kinases (ERKs) (Marshall, 1994) . Activated MAP kinases translocate to the nucleus where they phosphorylate many substrates, including transcription factors, resulting in immediate-early gene induction (Gille et al., 1995; Mariais et al., 1993; Marshall, 1995) . The Raf/MEK/MAPK cascade is thought to mediate Ras-growth promoting activities. Indeed, a Raf active mutant (Raf-CAAX), which is constitutively bound to the membrane, can induce malignant transformation in ®broblasts (Leevers et al., 1994) . Similarly expression of constitutively active MEK-1 is sucient to induce transformation of NIH3T3 cells, suggesting that in these cells activation of the MAP kinase pathway can reproduce Ras-proliferative response (Cowley et al., 1994; Mansour et al., 1994; Pages et al., 1994) .
The Rho/Rac family of GTP-binding proteins plays a crucial role in signals that mediate reorganization of the actin cytoskeleton and cell adhesion induced by Ras, although they do not interact directly with Ras. Rac regulates membrane rues (lamellipodia) through formation of cortical actin ®bers , whereas Rho controls stress ®ber and focal adhesion formation Nobes and Hall, 1995) . The Rho/Rac signaling pathway is also involved in regulation of cell proliferation and gene expression (Hill et al., 1995; Minden et al., 1995; Olson et al., 1995; Yamamoto et al., 1993) . Accordingly, Rac-1 has been shown to be required for Ras transformation in ®broblasts and a constitutively active form of Rac-1 (Val12-Rac) can by itself act as a weak oncogene, inducing the hallmarks of malignant transformation (Qiu et al., 1995) .
While the role of Ras downstream pathways in malignant transformation has been extensively studied in ®broblasts, little is known about their eects in other systems, most notably in epithelial cells, where Ras mutations are most frequently found (Bos, 1989; Clark and Der, 1993 ). An important feature of epithelial cells is that transformation results in increased proliferation coupled with decreased dierentiation. Thyroid follicular cells are highly specialized epithelial cells which are devoted to synthesis, storage and release of thyroid hormones. This process requires the expression of a set of cell-type-speci®c gene products, which include thyroglobulin (TG), thyroperoxidase (TPO), thyroidstimulating hormone receptor (TSH-R) and Na + /l 7 symporter (NIS) (Damante and Di Lauro, 1994) . Studies on the TG and TPO promoters have allowed the identi®cation of three thyroid-speci®c transcription factors, TTF-1 (Thyroid Transcription Factor-1), TTF-2 (Thyroid Transcription Factor-2) and Pax-8 (belonging to the family of the paired domain proteins), involved in the onset and maintenance of the dierentiation status (Guazzi et al., 1990; Zannini et al, 1992 Zannini et al, , 1997 . These transcription factors are expressed during thyroid development, in the adult gland, as well as in a few other sites and their concomitant expression is unique to thyroid cells (Civitareale et al., 1989; Lazzaro et al., 1991; Missero et al., 1997; Zannini et al., 1997) .
Unlike terminally dierentiated cell lineages, which undergo cell cycle withdrawal upon induction of terminal dierentiation, thyroid cells in culture respond to the thyroid-stimulating hormone (TSH), both proliferating and maintaining the expression of tissue-speci®c markers (Ambesi-Impiobato et al., 1982) . Activation of the TSH-R, a G-protein coupled receptor, results in stimulation of adenylyl cyclase, elevation of cAMP levels and cAMP-dependent protein kinase (PKA) activation (Vassart and Dumont, 1992) . Recent ®ndings suggest that Ras activation plays a role in mitogenic signal transduction induced by G-proteincoupled receptors (Alblas et al., 1993; Chen et al., 1996; Dikic et al., 1996; Sadoshima and Izumo, 1996) . Indeed in thyroid cells, proliferation is dependent both on Ras as well as on PKA activation, since a dominant-interfering Ras mutant causes a signi®cant reduction of TSH-induced proliferation (Kupperman et al., 1993) .
Several reports on high frequency of Ras mutations in both benign and malignant follicular neoplasms, suggest that Ras activation is an early event in thyroid tumorigenesis (Farid et al., 1994; Lemoine et al., 1990; Namba et al., 1990; Suarez et al., 1990) . Previous Figure 1 Expression of MEK-1 and Rac-1 mutants in thyroid follicular cells. (a) FRTL-5 cells were stably transfected with HAtagged-MEKDN3/S218E/S222D expression vector (MEK) or with vector alone (CTR). Neomycin resistant colonies were isolated and analysed by immunoblotting, using anti-HA antibodies (a-HA). A 43 KDa band, corresponding to exogenous MEK-1 protein was detected in several independent clones, two of which were selected for further studies (MEK#1 and MEK#2). (b) Myc-tagged Val-12 Rac expressing plasmid (Rac) or vector alone (CTR) were stably transfected in FRTL-5 cells together with an hygromycin resistance gene. Hygromycin-resistant colonies were selected and analysed by immunoblotting with anti-Myc antibodies (a-Myc). A 21 KDa band, corresponding to the exogenous Rac protein was detected in three independent clones (Rac#1, Rac#2, Rac#3). (c) Concomitant expression of both constitutively active MEK and Rac mutants was obtained by transfecting Val-12 Rac expression plasmid in FRTL-5 stably transfected with MEKDN3/S218E/S222D. Cells were cultured in the presence of neomycin and hygromycin, and selected clones (MEK/Rac#1, MEK/Rac#2, MEK/Rac#3) were tested for expression of both exogenous genes by immunoblotting with anti-HA and anti-Myc antibodies. Similar results were obtained by simultaneous cotransfection of MEKDN3/ S218E/S222D and Val-12 Rac in FRTL-5 cells studies have shown that oncogenic Ras causes potent tumorigenic transformation of these cells, resulting in growth factor-independent proliferation, morphological transformation, anchorage-independent growth and tumor formation when cells are injected into nude mice (Fusco et al., 1987) . Furthermore, in cells transformed by Ras as well as by a variety of other oncogenes, thyroid dierentiation is suppressed (Avvedimento et al, 1985; Francis-Lang et al., 1992) . Loss of the dierentiated phenotype is a common feature of malignant transformation. In the wellcharacterized muscle system, oncogenic H-Ras represses myogenic dierentiation by inhibiting expression of muscle-speci®c transcription factors and, at the same time, inactivating their function without altering dimerization, DNA binding or transactivating functions, with a mechanisms that is poorly understood (Kong et al., 1995) . Similarly, inhibition of thyroid dierentiation upon H-Ras transformation is associated with loss of PAX-8 and TTF-2 expression, and with TTF-1 inactivation even if its DNA-binding activity and transactivating function are not aected Missero et al., 1997) .
To de®ne the downstream eectors of Ras signal transduction involved in thyroid epithelial cell transformation and in repression of the dierentiated phenotype, we have investigated the role of two key mediators known to be essential in ®broblasts for Rasinduced malignant transformation. For this purpose, we have generated thyroid cell lines stably transfected with either a constitutively active form of MEK-1 (MEKDN3/S218E/S222D) (Mansour et al., 1994) , a constitutively active form of Rac-1 (Val12-Rac) or both. We found that activation of neither MAP kinase nor Rac cascades can induce substantial changes in thyroid cell proliferative potential, although is sucient to induce morphological changes and colony formation in soft agar at low eciency. Concomitant activation of both pathways leads to hormone-independent proliferation, phenotypic transformation and colony formation in soft agar. However, in contrast to Ras transformed cells, morphologically transformed MEK and Rac thyrocytes display an unaltered thyroid dierentiation program and are unable to form tumors in nude mice. Figure 2 Stably transfected MEK and Rac mutants constitutively activate MAP kinase and Jun kinase respectively, in thyroid follicular cells. (a and c) MAP kinase activation was measured by a two step in vitro kinase assay on total cell extracts in FRTL-5 cells and in constitutively active MEK#1 and #2 clones (a) as well as in Ras, Rac#1 and MEK/Rac#1 clones (c). As control, the experiment was also carried out in the absence of cell extract (CTR). In the ®rst kinase assay, inactive GST/ERK2 fusion protein was used as substrate, and was then puri®ed on glutathione-Sepharose gel. Puri®ed GST/ERK2 activity was measured using the myelin basic protein (MBP) as substrate in the presence of [g 32 -P]ATP. Phosphorylated MBP was then resolved on a 15% SDS ± polyacrylamide gel and detected by autoradiography. 
Results

Stable expression of constitutively active forms of MEK-1 and Rac-1 in thyroid cells
The rat thyroid follicular cell line FRTL-5 provides a useful model to study growth and dierentiation of specialized epithelial cells. Expression of the viral HRas gene in these cells leads to malignant transformation, resulting in growth factor-independent proliferation, colony formation in soft agar, loss of the dierentiated phenotype and tumor formation upon injection in nude mice (Fusco et al., 1987) . In ®broblasts activation of MEK-1 and Rac-1 can reproduce Ras eects, inducing full tumorigenic transformation. To explore the contribution of these two key mediators in thyroid cell transformation, FRTL-5 cells were stably transfected with either an HA-tagged constitutively active form of MEK-1 (MEK DN3/S218E/S222D ) (Mansour et al., 1994) or a Myctagged constitutively active form of Rac-1 (Va12-Rac) . Transfected FRTL-5 clones were tested for MEK DN3/S218E/S222D expression by immunoblotting analysis of total cell extracts, using anti-HA antibodies. Two neomycin-resistant clones, expressing the active MEK-1 mutant were selected for further studies ( Figure 1a) . Similarly, three neomycin-resistant clones were selected which expressed Val-12 Rac to similar levels as detected with anti-Myc antibodies ( Figure 1b) . Cooperation between MEK and Rac cascades was explored by transfection of Val12-Rac gene into FRTL-5 cells carrying MEK DN3/S218E/S222D . Three FRTL-5 clones were isolated that expressed both genes, as detected by immunoblotting using anti-HA and anti-Myc antibodies respectively, and were consequently used for further analysis (Figure 1c ). Val12-Rac expression levels obtained in the MEK/Rac coexpressing cells were comparable to those of the lines expressing only Val12-Rac (data not shown). The phenotype of these cells was compared to that of a FRTL-5/Ras clone, obtained by stable transfection of a pZip plasmid encoding v-H-Ras (see Materials and methods) which was shown to completely mimic the virally infected cells used in previous studies (FrancisLang et al., 1992) .
To con®rm activation of the MAP kinase pathway in the stably transfected FRTL-5 cells carrying MEK DN3/S218E/S222D , a kinase assay was performed on total cell extracts using a GST/ERK-2 fusion protein as substrate, whose activation was in turn tested by ERK2 ability to phosphorylate the myelin basic Figure 3 Proliferative activity of thyroid follicular cells carrying either v-H-Ras or active MEK (MEK#1), Rac (Rac#2) and MEK/Rac mutants (MEK/Rac#1). The percentage of cells in Sphase was measured in the presence (black bars) or in the absence (white bars) of TSH and insulin. Cells were cultivated for 72 h in the absence of TSH and insulin at low serum concentration. TSH and insulin were added back into the medium and DNA synthesis was measured after 24 h, by labeling the various cell lines with BrdU for 18 h. BrdU incorporation was detected by immunostaining with anti-BrdU antibodies, while total number of nuclei was evaluated by staining with Hoechst 33258 as described in Materials and methods. A minimum of 400 nuclei in four independents ®elds was counted in all cases. Similar experiments were performed with all clones with similar results Figure 4 Analysis of dierentiation marker expression in thyroid follicular cells carrying the active MEK and Rac mutants or oncogenic Ras. (a) Northern blot analysis was performed on total RNA samples derived from the various cell lines, using rat TPO and NIS cDNA fragments as probes (see Material and methods). The ®lter was also probed with rat GAPDH as loading control. (b) Same amounts of total cell extracts were analysed by a 4 ± 15% gradient SDS ± polyacrilamide gel and immunoblotted with thyroglobulin-speci®c polyclonal antibodies (TG). The 300 KDa thyroglobulin band in Ras-transformed cells could not be detected even at higher exposures. The ®lter was also probed with antibodies against a non-related protein as a control for equal loading conditions (data not shown). Similar results were obtained in at least two other independent experiments protein (MBP). MAP kinase was found to be approximately 3 ± 4-fold more active in the selected clones than in FRTL-5 controls (Figure 2a) . Activation of the Rac cascade has been shown to stimulate JNK/ SAPK kinase activity. JNK-1 was immunoprecipitated with speci®c antibodies and its activity was measured in an in vitro kinase assay, using GST-c-JUN fusion protein as substrate. As shown in Figure 2b , FRTL-5 cells expressing Val12-Rac displayed a 3 ± 5-fold higher JNK activity than FRTL-5 controls.
To test for cross-talk between the MAPK and Rac cascades in our clones, we compared ERK-2 and JNK-1 activity in control FRTL-5 cells, in Ras, in MEK#1, in Rac#1 and in MEK/Rac#1 clones.
As shown in Figure 2c , ERK-2 activity appears to be almost exclusively controlled by the MAPK pathway. Conversely, JNK-1 activity is stimulated both by MAPK and by Rac cascades, even though the latter is more ecient in stimulating c-JUN phosphorylation (Figure 2d) . The v-H-Ras transformed cells show, as expected, an enhanced ERK and JNK activation compared to FRTL-5 control (Figure 2c and d) .
Concomitant activation of MEK-1 and Rac-1 leads to growth factor-independent proliferation of thyroid follicular cells
The thyrotropin hormone (TSH) is required for thyroid follicular cell proliferation both in vivo and in vitro (Ambesi-Impiombato et al., 1982) . Quiescent FRTL-5 cells can be induced to enter into the cell cycle by TSH, although sustained proliferation requires also the presence of insulin and serum. Ras transformation induces proliferation of FRTL-5 cells even in the absence of TSH or any other growth factors (Fusco et al., 1987) .
To determine whether MAP kinase or Rac cascades can reproduce the Ras phenotype, FRTL-5 clones expressing MEK DN3/S218E/S222D , Val12-Rac or both were tested for their ability to grow in the absence of hormones. The various cell types were cultured at low serum concentration (0.2%) in the absence of hormones for 72 h and then stimulated with TSH and insulin. After 24 h, entry into S-phase was monitored by incorporation of the thymidine analog bromodeoxyuridine (BrdU) for 18 h, since preliminary experiments had shown that DNA synthesis in FRTL-5 begins 25 ± 30 h after hormones stimulation. Similarly to untransfected controls, FRTL-5 cells carrying either constitutively active MEK-1 or Rac-1 constructs were found to be still dependent on growth factors, being unable to enter into the cell cycle in the absence of TSH and insulin, while hormone addition could restore DNA synthesis (Figure 3 ). In contrast, concomitant expression of MEK DN3/S218E/S222D and Val12-Rac in FRTL-5 clones resulted in cell cycle entry even in the absence of hormones (Figure 3) , although the number of cells entering into S-phase was signi®cantly lower than in the case of Ras-transformed cells (Figure 3) . Similar results were obtained by hormone starvation in the presence of 5% calf serum (data not shown).
Thus, concomitant activation of MEK-1 and Rac-1 is sucient to allow cell cycle progression in FRTL-5 cells independently of exogenous signals, suggesting that cooperation between these Ras downstream pathways is sucient for FRTL-5 cell proliferation.
Activation of MEK-1 and Rac-1 is not sucient to alter thyroid cell dierentiation Malignant transformation causes loss of the differentiated phenotype in several cellular systems in vitro, as well as in vivo. Accordingly, in FRTL-5 cells, Rastransformation results in loss of expression of a Figure 5 Activity of thyroid-speci®c transcription factors in FRTL-5 cells carrying an oncogenic Ras or MEK/Rac constitutively active mutants. (a) An arti®cial promoter C5E1B, speci®cally responding to TTF-1, fused to CAT reporter gene was transiently transfected into the indicated stable FRTL-5 clones and its activity was measured as described in Material and methods. Data are expressed as fold of induction of C5E1B activity versus the minimal promoter E1B. (b) A similar experiment of a was performed using CP5E1b-CAT, speci®cally responding to Pax-8, as a reporter gene. These experiments were performed in triplicate and were repeated twice with similar results number of dierentiation-speci®c markers (FrancisLang et al., 1992) .
To examine the eect of MAP kinase and Rac activation on thyroid dierentiation, expression of thyroid-speci®c proteins was measured in FRTL-5 clones carrying either the constitutively active MEK, Rac or both. As shown in Figure 4a , TPO and NIS mRNA levels were not signi®cantly aected by activation of MEK-1 and Rac-1, while oncogenic Ras could completely abolish their expression. Similarly, immunoblotting analysis of total cell extracts revealed that TG was expressed in all analysed clones, even if a very modest decrease in its expression could be detected in two of the MEK/Rac clones, but not in the other. In contrast Ras-transformed FRTL-5 cells showed no TG signal, even at longer exposures ( Figure 4b) .
As previously demonstrated, expression of thyroidspeci®c markers is under transcriptional control of TTF-1 and PAX-8 . In FRTL-5 cells carrying the activated v-H-Ras oncogene, TTF-1 protein, although present at nearly wild-type levels, is inactive, while no PAX-8 mRNA can be detected . To analyse the transcriptional activity of TTF-1 and PAX-8 in the various FRTL-5 clones, we have used C5E1b and CP5E1b, two arti®cial promoters which are active in dierentiated thyroid cells and speci®cally respond to TTF-1 and PAX-8 respectively (Missero et al., 1997) . Control cells transiently transfected with C5E1b and CP5E1b, generated the expected high levels of reporter gene activity, relative to the E1b basal promoter (Figure 5a and b). Transcriptional activity of these promoters was completely abolished in Ras-transformed cells. In contrast, expression of MEK-1, Val-12 Rac or MEK/ Rac mutants had little eect on TTF-1 and PAX-8 activities, resulting in reporter gene expression comparable to control cells (Figure 5a and b) .
Thus, in contrast to Ras, activation of MEK-1 and Rac-1 had very little eect, if any, on TTF-1 and PAX-8 activities or on thyroid-speci®c protein expression, suggesting that Ras may exert its inhibitory activity on dierentiation independently of these molecules.
Activation of MEK-1 and Rac-1 is not sucient to induce full tumorigenic transformation in thyroid cells
The Ras oncogene promotes tumorigenicity in cultured thyroid cells and is activated in naturally occurring thyroid tumors (Fusco et al., 1987; Rochefort et al., 1996) . Since MEK-1 and Rac-1 activation can mimic Ras-induced transformation in ®broblasts, we sought to test whether activation of these molecules is sucient to cause malignant transformation also in epithelial cells, such as the thyroid follicular cells.
The biological properties of stably transfected FRTL-5 cells were evaluated. Untransfected FRTL-5 cells, as well as transfected controls carrying the neomycin resistant gene, displayed the characteristic at, well adherent phenotype of thyroid cells and grew in compact colonies (Figure 6a ). In contrast, FRTL-5 carrying both MEK-1 and Rac-1 mutants showed a morphologically transformed phenotype similar to Ras-transformed cells. They displayed a ®broblastoid bipolar shape, were less adherent and more refractile, appearing to have lost the characteristic contacts between cells and growing preferentially apart one to each other, until they reached con¯uency. Activation of either MEK-1 or Rac-1 alone led to an intermediate phenotype, with only partial formation of compact colonies and transformed appearance of individual cells.
We ®rst tested the ability of MEK DN3/S218E/S222D and Val12-Rac expressing FRTL-5 to form colonies in soft agar. As expected Ras-transformed FRTL-5 generated colonies in soft agar at high eciency (Table 1; Figure  6b ). Expression of either constitutively active MEK-1 or Rac-1 was also sucient to induce colony formation in soft agar, even if to a lower extent than that of Rastransformed cells. Importantly, concomitant expression of constitutively active MEK-1 and Rac-1 resulted in growth in soft agar, at an eciency very similar to the one induced by Ras (Table 1; Figure 6b ). Thus, activation of MAP kinase and Rac cascades is sucient to reproduce the anchorage-independent growth elicited by the Ras oncogene.
FRTL-5 cells expressing MEK DN3/S218E/S222D and Val12-Rac were also tested for their ability to induce tumors in vivo by subcutaneous inoculation into athymic nude mice. Ras transformed cells generated tumors within two weeks, which grew progressively. In contrast, no tumors were formed during a period of ®fty days in mice inoculated with the same number of FRTL-5 cells carrying both constitutively active mutants (Table 1) .
These data suggest that in thyroid epithelial cells activation of MEK-1 and Rac-1 results in the ability to grow in the absence of substrate, but is not sucient to induce tumor formation.
Discussion
Constitutive activation of MEK-1 and Rac-1 has been shown to reproduce Ras-induced malignant transformation in ®broblasts. Since Ras mutations occur frequently in epithelial cells, we have tested the eects of MEK-1 and Rac-1 activation in thyroid follicular cells, where both proliferative as well as dierentiation response can be measured. Concomitant activation of these two key signal transduction regulators in thyrocytes leads to abnormal growth control and morphological transformation, but it is unable to cause tumorigenicity in nude mice or to extinguish dierentiation.
We show in this paper that stable expression of activated MEK-1 alone in thyroid epithelial cells leads to a partial transformed phenotype, as shown by the induction of anchorage-independent growth and altered morphology. However, in contrast to fibroblasts, thyroid cells expressing the constitutively active MEK-1 mutant are unable to proliferate independently of growth factors, despite a constitutively elevated MAP kinase activation. This could be due to the low MAP kinase activation achieved in stably transfected cells as compared to transiently transfected ones (this paper and M. McMahon, personal communication). We do not favor this hypothesis, since it has been shown in the case of the Raf family members, which act directly upstream of MEK, that a high MAP kinase activation is not required for long term eects on cell proliferation, and in fact there is an inverse correlation between mitogenic properties and the ability to induce MAP kinase activation among the dierent Raf forms (Bosch et al., 1997) . The role of MAP kinase activation in epithelial transformation has been explored in other cell systems. In rat intestinal cells as well as in human mammary epithelial cells constitutively active Raf mutants, which induce full malignant transformation in NIH3T3, are unable to induce morphological transformation, growth in soft agar or tumors in nude mice (Oldham, 1996) . Thus, taken together our and previous work suggests that the Raf/MEK/MAP kinase cascade is insucient to induce full malignant transformation in epithelial cells. The role of the small GTPase Rac-1 in epithelial cell proliferation and transformation has not been well characterized and may be cell type-dependent. It has been recently shown that Val-12 Rac can partially revert Ras-induced transformation of epithelial kidney cells, by promoting E-cadherin-mediated cell-cell adhesion (Hordijk et al 1997) . On the other hand, in mammary epithelial cells Val-12 Rac has been shown to disrupt normal polarization and promote integrinmediated cell motility and invasiveness (Keely et al., 1997) . We show here that expression of a constitutively active Rac-1 mutant in thyroid cells leads to JNK activation, morphological changes and anchorageindependent proliferation, but is unable to induce growth factor-independent growth. Thus, in thyroid epithelial cells expression of either MEK DN3/S218E/S222D or Val-12 Rac results in anchorage-independent growth, morphological changes and a modest reduction in cellcell contacts, while, in contrast to activated Ras, neither of the two mutants was able to promote growth factor-independent growth, to interfere with dierentiation or to induce tumorigenicity.
Concomitant expression of activated MEK-1 and Rac-1 in thyroid cells act in a synergistic fashion to induce growth factor-independent proliferation, even if the proliferation rate of the double mutant cell line is not as high as that observed in Ras-transformed cells. Growth factor-independent proliferation could be achieved by the combination of these two pathways either by activation of dierent eectors, acting independently on the cell cycle, or by activation of common downstream regulators. Interestingly, Rac-1 has been recently shown to induce MAP kinase activation through PAK-mediated MEK-1 phosphorylation (Frost et al., 1997) . However the role of this pathway is not well understood, since a Rac-1 mutant that is unable to activate either PAK or JNK can still induce S phase entry of quiescent Swiss 3T3, suggesting that PAK is not required for G1 progression and that Rac-induced cell cycle progression occurs through a dierent mechanism (Lamarche et al, 1996) .
Thyroid cells expressing both activated MEK-1 and Rac-1 also show an increased eciency of anchorageindependent proliferation, similar to that observed with Ras transformed cells, yet they are unable to induce tumors in nude mice. These observations are of interest, since in most cases cells able to grow in soft agar can also generate tumors in nude mice, and suggest that additional requirements for in vivo tumorigenesis exist.
We show in this paper that concomitant activation of MEK-1 and Rac-1 is unable to reproduce Ras eect on dierentiation, leaving thyroid dierentiation unaltered. The inability of MEK-1 and Rac-1 mutants to aect thyroid cell dierentiation may be one cause of their inability to induce tumorigenicity. Other possibilities should be also taken into account. We have shown that cells carrying constitutively active MEK-1 and Rac-1 mutants, proliferate in the presence or in the absence of growth factors at a rate similar to normal counterparts grown in the presence of growth factors. In contrast, Ras transformed thyroid cells proliferate faster, and such an high rate of proliferation could be essential for tumor formation in vivo. In addition Ras is known to protect cells from apoptosis through an AKT/PKB-dependent mechanism (Kennedy et al., 1997) . Since neither MEK-1 or Rac-1 are able to activate this pathway, it is conceivable that cells carrying MEK-1 and Rac-1 might be more susceptible to apoptosis during tumor formation, even if their rate of apoptosis in thyroid cell cultures is very low and comparable to wild type controls (GC and CM, unpublished observations).
Given that activation of both MEK-1 and Rac-1 is unable to extinguish dierentiation, other Ras eectors are likely to be involved in this phenotype. A number of proteins have been shown to interact directly with the GTP-bound form of Ras, including Raf (Aelst et al., 1993; Vojtek et al., 1993; Warne et al., 1993; Zhang et al., 1993) , the catalytic subunit of the phosphatidylinositol 3-kinase (PI3-K) (Rodriguez-Viciana et al., 1994) , the GTPase-activating proteins (Polakis and McCormick, 1993) , and RalGDS (Kikuchi et al., 1994) . In thyroid cells, RalGDS pathway has been shown to be active and to participate in TSH-induced DNA synthesis (Miller et al., 1997) . However, since inactivation of RalGDS has no eect on cAMP response element (CRE) regulated gene expression (Miller et al., 1997) , it is unlikely that this pathway plays a major role in the expression of the thyroid dierentiated phenotype. Another Ras eector that could be potentially involved in thyrocyte differentiation control and transformation is PI3-K (Klippel et al., 1996; Rodriguez-Viciana et al., 1994) . In ®broblasts dominant-negative forms of PI3-K are able to inhibit signi®cantly Ras transformation (Rodriguez-Viciana et al., 1997) . Recent lines of evidence place PI3-K upstream of Rac-1, to control membrane ruing (Rodriguez-Viciana et al., 1997) . We have shown here that Rac activation is not involved in the repression of thyroid dierentiation, however other pathways downstream of PI3-K, as for instance the one leading to AKT/PKB activation, could be functionally important (Burgering and Coer, 1995) .
Most of the studies on Ras functions have focused their attention on its eector region, which is thought to be crucial for Ras interaction with downstream molecules (White et al., 1995) . We have evidence that some eects on thyroid dierentiation may not be mediated exclusively by the Ras eector region, since viral H-Ras and viral K-Ras, which share an identical eector region, impair thyroid dierentiation with dierent mechanisms . Thus, the mechanisms through which Ras blocks thyrocyte dierentiation are likely to be very complex and will require further investigations. In agreement with our ®ndings is a recent report on the eects of Ras downstream pathways on muscle cell differentiation. Even in this case, activation of the Rac/Rho or the MAP kinase cascades is not sucient to aect skeletal myogenesis, further suggesting that another as yet unidenti®ed pathway could be involved in dierentiation repression (Ramocki et al., 1997) .
In conclusion, our data suggest that thyroid cell dierentiation is likely to be aected by Ras through a novel pathway that is independent of MAP kinase and Rac cascades. These data suggest that additional biochemical events initiated by Ras may be involved in loss of dierentiation and the same events could also be required for full malignant transformation.
Materials and methods
Cell culture and transfection assay FRTL-5 cells were grown in Coon's modi®ed F-12 medium (Sigma) supplemented with 5% calf serum (Life Technologies, Inc.) and six growth factors including TSH (1 mu/ ml) and insulin (10 mg/ml) as previously described (Ambesi-Impiombato et al., 1982) .
Transfections were carried out by the calcium phosphate-DNA precipitation essentially as previously described . Brie¯y, calcium phosphate-DNA precipitates were prepared with 10 mg of plasmid DNA containing either constitutively active mutant of HAtagged MEK-1 (MEKDN3/S218E/S222D) (Mansour et al., 1994) or Myc-tagged Val12-Rac-1 , 1 mg of plasmid DNA containing the neomycin resistance gene under the viral LTR promoter, and 40 mg of calf thymus genomic DNA as carrier (Boehringer Mannheim). Cells were selected with 300 mg/ml of G418 (Sigma). After 3 weeks, G418-resistant colonies were isolated and expanded. HA-MEK-1 expressing clones were further subjected to transfection with 10 mg of plasmid DNA containing Myc-tagged Val12-Rac1 to obtain concomitant expression of both mutants in the presence of 1 mg of plasmid DNA containing the hygromycin resistance gene under the RSV promoter. Cells were selected with 250 mg/ml of hygromycin (Sigma). FRTL-5/Ras clones were obtained transfecting 10 mg of plasmid DNA, pZIP-Neo vector (Cepko et al., 1984) encoding the v-H-Ras allele. Cells were selected with 300 mg/ml of G418 (Sigma). G418-resistant colonies expressing v-H-Ras were identi®ed using a pan-Ras antibody (Santa Cruz Biotechnology, Inc.).
For transient transfection assays, cells were plated at a density of 5610 5 /60 mm diameter tissue culture dish and 3 mg of each promoters (C5E1b or CP5E1b) driving CAT was transfected together with 1 mg of CMV-Luc as internal control. After 48 h cell extracts were prepared in lysis buer (10 mM HEPES pH 7.9, 400 mM NaCl, 0.1 mM EGTA, 0.5 mM DTT, 5% glycerol, 0.5 mM PMSF) and then chloramphenicol acetyltransferase and luciferase activities were determined (de Wet et al., 1987; Gorman et al., 1982) .
Immunoblotting
Whole-cell lysates of stably transfected cells were prepared in sample buer, normalized for equal concentration of protein by the Bradford assay (Bio-Rad). Forty mg of protein samples were resolved on SDS ± PAGE at the concentrations indicated in the ®gure legends, and transferred on a PVDF membrane (Millipore). Monoclonal 12CA5 antibodies (0.5 mg/ml) used to detect the HA tag were purchased from Boehringer Mannheim; Anti-Myc monoclonal antibodies (9E10; 1 mg/ml) were purchased from Santa Cruz Biotechnology, Inc. Anity puri®ed polyclonal Ab anti-thyroglobulin were previously obtained in our laboratory and used at approximately at 1 mg/ml (Mascia et al., 1997) . Immune complexes were detected by enhanced chemiluminescence as instructed by the manufacturer (Amersham Life Sciences, PLC).
Protein kinase assays
MEK-1 activity was measured in total cell extracts for its ability to activate MAPK, which was in turn assayed by in vitro kinase assay using the myelin basic protein (MBP) as substrate, as previously described (Lange-Carter and Johnson, 1995) . Brie¯y, cells were lysed in lysis buer (20 mM Tris/acetate pH 7.5, 0.27 M sucrose, 1 mM EDTA, 1 mM EGTA, 1 mM sodium orthovanadate, 10 mM sodium b-glycerophosphate, 50 mM sodium¯uoride, 5 mM sodium pyrophosphate, 1% Triton X-100, 0.1% 2-mercaptoethanol, 1 mM benzamidine, 0.2 mM PMSF, 5 mg /ml leupeptin, 0.5 mM okadaic acid, 1 mM PKI) and 15 mg of total cell extracts were incubated in a ®rst kinase assay at 308C for 30 min in the presence of GST-ERK-2 and cold ATP. Activated GST-ERK-2 was recovered on glutathioneSepharose beads, washed and dissociated from the beads with glutathione (20 mM, pH 7.5). Activation of GST-ERK-2 was measured in a second kinase assay, using MBP (GIBCO ± BRL) as a substrate in the presence of [g-32 P]ATP. Samples were subjected to a 15% SDS ± PAGE gel and autoradiography.
JNK-1 activity was measured by immunoprecipitating endogenous JNK-1 from 200 mg of dierent cell lysates in RIPA buer using anity puri®ed polyclonal antibodies raised against JNK-1 (C-17, Santa Cruz Biotechnology, Inc.). Protein A-Sepharose was then added and immunocomplexes were incubated at 308C in a reaction mix containing 140 mM HEPES pH 7.5, 140 mM b-glycerophosphate, 70 mM pnitrophenylphosphate, 70 mM MgCl 2 , 7 mM DTT, 0.35 mM sodium orthovanadate, 40 mM ATP and 0.2 ml [g-32 P]ATP, in the presence of 250 ng of bacterial puri®ed c-Jun. Phosphorylated c-Jun was then resolved on a 10% SDS ± PAGE. The gel was ®xed and stained with Coomasie blue and subjected to autoradiography (Westwick and Brenner, 1995) .
Bromodeoxyuridine incorporation
FRTL-5 cell lines were plated in 2-well chamber slides at a density of 5610 4 cells/well in complete medium. After 48 h cells were switched in low serum medium (Coon's modi®ed F12 medium with 0.2% calf serum) for 72 h, then TSH and insulin were added back at the concentration of 1 mU/ml and 10 mg/ml respectively. After 24 h incubation, DNA synthesis was measured by 18 h pulse with 10 mM bromodeoxyuridine (BrdU, Amersham Life Sciences). Cells were ®xed and permeabilized for immunofluorescence.
Immuno¯uorescence
Cells were ®xed in 2% paraformaldehyde in PBS for 10 min at 378C and washed extensively with PBS. Cells were then permeabilized in PBS/0.1% NP-40 and incubated with 5% goat serum. Primary antibody incubation was performed for 2 h at room temperature using monoclonal antibodies against BrdU (Becton Dickinson) in the presence of 1 mg/ml of DNAse (Sigma). After extensive wash in PBS/0.1% NP-40, the cells were incubated in uorescein-conjugated goat anity puri®ed antibody to mouse IgG (Cappel) for 1 h at room temperature and then washed several times with PBS/0.1% NP-40. Before the last wash, cells were incubated for 2 min with Hoechst (Sigma), mounted under a glass coverslip with 50% glycerol in PBS and then analysed by microscopy (Axiophot Zeiss). Fluorescence images were recorded on Kodak 400 ASA ®lms.
RNA isolation and analysis
Total RNA was isolated from cultured cells by guanidine hydrochloride procedure as previously described (Chomczynski and Sacchi, 1987) . Thirty mg of RNA was run on a 1% agarose gel and transferred to Hybond N + nylon (Amersham Life Sciences) and hybridized in Church and Gilbert buer (Church and Gilbert, 1984) . The blot was probed with either a cDNA fragment of rat TPO (nucleotide 7155 to +355), of rat NIS (nucleotide 1804 to 2046), and a 300 bp fragment in the 3' region of the rat GAPDH, labeled by random priming with a-32 P-ATP (Amersham Life Science).
Transformation assays
Growth in soft agar was based on the Macpherson and Montagnier method (Cowley et al., 1994) . Brie¯y, each transfected cell line was seeded at 5610 4 cells per 60 mm dish in growth medium containing 0.25% agar over a base layer of 0.6% and then incubated for 4 weeks. Cells were fed weekly with 1 ml of medium. The number of colonies per plate was divided by the number of cells plated to calculate the eciency of colony formation. Colonies larger of 50 cells were scored as positive.
To investigate tumorigenicity in nude mice, cells were trypsinized and resuspended in complete medium at a density of 1610 7 /ml, and 0.2 ml were then injected subcutaneously into each¯ank of athymic nude mice in duplicate. Mice were sacri®ced 4 weeks after injections and tumors scored.
